GAMMA Investing’s Wave Life Sciences WVE Stock Holding History

GAMMA Investing’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.77K	Sell	476 -156	-25%	-$1.03K	﹤0.01%	3667
2026 Q1	$4.58K	Sell	632 -60	-9%	-$782	﹤0.01%	3391
2025 Q4	$11.8K	Buy	692 +251	+57%	+$2.55K	﹤0.01%	2904
2025 Q3	$3.23K	Sell	441 -75	-15%	-$607	﹤0.01%	3322
2025 Q2	$3.35K	Buy	516 +151	+41%	+$997	﹤0.01%	3257
2025 Q1	$2.95K	Buy	365 +61	+20%	+$667	﹤0.01%	3282
2024 Q4	$3.76K	Buy	304 +160	+111%	+$2.14K	﹤0.01%	3024
2024 Q3	$1.18K	Buy	144 +110	+324%	+$658	﹤0.01%	3212
2024 Q2	$170	Sell	34 -28	-45%	-$160	﹤0.01%	3371
2024 Q1	$383	Buy	+62	New	+$310	﹤0.01%	3143

Other funds holding WVE

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

APM

a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return

CCM

Capstone Capital Management Hong Kong $224M AUM

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

GAMMA Investing's WVE Position: Q2 2026 in Review

GAMMA Investing reduced its Wave Life Sciences (WVE) stake by 25% in Q2 2026, selling an estimated $1.03K and leaving 476 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #3667.

GAMMA Investing first reported a position in WVE in Q1 2024 and has held it in 10 quarters since. The position peaked at $11.8K in Q4 2025. 28 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

GAMMA Investing held 476 shares of Wave Life Sciences worth $2.77K as of Q2 2026.
GAMMA Investing sold 156 Wave Life Sciences shares in Q2 2026, an estimated $1.03K.
Wave Life Sciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3667 holding.
GAMMA Investing first reported a position in Wave Life Sciences in Q1 2024 and has held it in 10 quarters since.
GAMMA Investing's Wave Life Sciences position peaked at $11.8K in Q4 2025.
28 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.